Vaccine News and Research

Latest Vaccine News and Research

Novel lysin therapy shows promise for fighting drug-resistant bacteria

Humans are in a constant arms race with infectious bacteria. To kill these disease microbes, we develop powerful antibiotics; and in turn, the bacteria develop resistance against these drugs.

5 Feb 2019

Researchers move a step closer to developing new pneumonia vaccine

A vaccine against the biggest bacterial killer on the planet is a step closer to being available with funding secured for preclinical trials.

4 Feb 2019

Researchers harness immune system to reveal new clues to produce HIV vaccine

The immune system is the body's best defense in fighting diseases like HIV and cancer. Now, an international team of researchers is harnessing the immune system to reveal new clues that may help in efforts to produce an HIV vaccine.

4 Feb 2019

Vaccination with live S. mitis may offer protection from Streptococcus pneumoniae

Vaccinating laboratory mice with Streptococcus mitis bacteria prevents their virulent sibling, Streptococcus pneumoniae from infecting the mice.

30 Jan 2019

Having vaccine after shingles appear do not reduce the risk of stroke

Stroke risk increased significantly in the days, weeks and months after shingles appeared, despite use of the shingles vaccine and antiviral therapy to treat it, according to preliminary research to be presented in Honolulu at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

30 Jan 2019

New precision medicine treatment for bone cancer in dogs opens door for human clinical trials

In a first-of-its-kind study, scientists at the University of Missouri have helped advance a patient-specific, precision medicine treatment for bone cancer in dogs.

29 Jan 2019

Measles outbreak in Clark County, Washington

A public health emergency has been declared in Washington with over two dozen cases of measles. Last Friday (25th January 2019), the Governor Jay Inslee said in a statement that there is an outbreak of measles and the Washington State Military Department and State Emergency Operations Center would be collaborating with the Department of Health to fight the outbreak.

28 Jan 2019

NIAID-funded clinical trial of Ebola vaccines is underway at Cincinnati Children's

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children's Hospital Medical Center in the United States. The study is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

28 Jan 2019

NIH researchers discover that anti-flu antibodies can inhibit two different viral proteins

Researchers from the National Institutes of Health have discovered that antibodies that may form the basis of a universal flu vaccine inhibit a second viral protein in addition to the one that they bind.

25 Jan 2019

Study: CD4+ T cells could be important mediators of protection against Zika virus

Immune cells called CD4+ T cells could be important mediators of protection against the Zika virus, according to a study published January 24 in the open-access journal PLOS Pathogens by Sujan Shresta of the La Jolla Institute for Allergy and Immunology, and colleagues.

25 Jan 2019

Thousands of girls in the UK have not been vaccinated against HPV

The PHE campaign to vaccinate all girls between the ages of 12 and 18 years against HPV was only achieved in two-thirds of the population between 2017-2018.

25 Jan 2019

Investigational Ebola treatment found to be safe in adults

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet.

25 Jan 2019

CMV vaccine provides a new way to fight malaria

Early research on a new approach to protecting against malaria is offering promising, potentially long-lasting results against the persistent parasite that sickens hundreds of millions people each year.

24 Jan 2019

LJI awarded $22 million contract renewal to host and expand Immune Epitope Database

La Jolla Institute for Immunology has been awarded a $22 million contract renewal over seven years from the National Institutes of Health to host and expand the Immune Epitope Database.

24 Jan 2019

Study demonstrates beneficial effects of influenza vaccination on COPD patients

A new study published in the January issue of CHEST establishes that patients with chronic obstructive pulmonary disease face heightened risks of death, critical illness, and hospitalization if they develop the flu and demonstrates the beneficial effects of influenza vaccination.

24 Jan 2019

Clinical testing begins for temperature-stable experimental tuberculosis vaccine

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis vaccine candidate.

23 Jan 2019

TGen identifies polio-like virus as potential cause of Acute Flaccid Myelitis outbreak

The Translational Genomics Research Institute, an affiliate of City of Hope, has identified a polio-like virus as a potential cause of an outbreak of a disease known as Acute Flaccid Myelitis (AFM), a crippling condition that causes muscle weakness and paralysis usually among children.

23 Jan 2019